Even when patients were stratified in quartiles depending on SMG1 expression in tumor samples, those with lower tumor levels of SMG1 displayed a CD8 phenotype with more abundance of cells expressing exhaustion markers (LAG3, PD-1, CTLA-4, TIM3, TOX) (Fig. 1H). The gene discussed is CD8A; the disease is neoplasm.